MAPT and Alzheimer disease: Serum p-tau (S202)/t-tau ratio also was not a reliable marker, distinguishing Mild-AD from AMC group subjects with 42.11% sensitivity and 76% specificity using a cut-off of 0.245 (AUC = 0.525, p = 0.78, Figure 1I).